[논문]Profiling and Identification of Omeprazole Metabolites in Mouse Brain and Plasma by Isotope Ratio-Monitoring Liquid Chromatography-Mass Spectrometric Method

Shin, Seok-Ho; Park, Yuri; Park, Min-Ho; Byeon, Jin-Ju; Lee, Byeong ill; Choi, Jangmi; Shin, Young G.

doi:10.3390/life10070115

[해외논문] Profiling and Identification of Omeprazole Metabolites in Mouse Brain and Plasma by Isotope Ratio-Monitoring Liquid Chromatography-Mass Spectrometric Method 원문보기

Life, v.10 no.7, 2020년, pp.115 -

Shin, Seok-Ho , Park, Yuri , Park, Min-Ho , Byeon, Jin-Ju , Lee, Byeong ill , Choi, Jangmi , Shin, Young G.

Abstract ▼ AI-Helper

Neuro–inflammation is known to be one of the pathogenesis for the degenerative central nervous system (CNS) disease. Recently various approaches for the treatment of brain diseases by controlling neuro-inflammation in the brain have been introduced. In this respect, there is a continuous demand for CNS drugs, which could be safer and more effective. Omeprazole, a well-known proton-pump inhibitor (PPI) is generally prescribed for the treatment of peptic ulcer. In addition to the anti-gastric acid secretion mechanism, recent studies showed that omeprazole or PPIs would likely have anti-inflammation effects in vitro and in vivo, but their effects on anti-inflammation in brain are still unknown. In this study, omeprazole and its metabolites in a mouse’s brain after various routes of administration have been explored by stable isotope ratio-patterning liquid chromatography–mass spectrometric method. First, a simple liquid chromatography–mass spectrometric (LC–MS) method was established for the quantification of omeprazole in mouse plasma and brain. After that, omeprazole and its stable isotope (D3–omeprazole) were concomitantly administered through various routes to mice in order to identify novel metabolites characteristically observed in the mouse brain and were analyzed using a different LC–MS method with information-dependent analysis (IDA) scan. With this unique approach, several new metabolites of omeprazole were identified by the mass difference between omeprazole and stable isotope in both brain and plasma samples. A total of seventeen metabolites were observed, and the observed metabolites were different from each administration route or each matrix (brain or plasma). The brain pharmacokinetic profiles and brain-to-plasma partition coefficient (Kp) were also evaluated in a satellite study. Overall, these results provide better insights to understand the CNS-related biological effects of omeprazole and its metabolites in vivo.

Keyword

참고문헌 (50)

1. Lo E.H. Degeneration and repair in central nervous system disease Nat. Med. 2010 16 1205 1209 10.1038/nm.2226 21052074

상세보기
2. Pei J.J. Sjogren M. Winblad B. Neurofibrillary degeneration in Alzheimer’s disease: From molecular mechanisms to identification of drug targets Curr. Opin. Psychiatr. 2008 21 555 561 10.1097/YCO.0b013e328314b78b 18852562

상세보기
3. Lee K.S. Suh H.-S. Alzheimer’s Disease: Clinical Trials and Future Perspectives Korean J. Psychopharmacol. 2012 23 131 135
4. Rich J. Degenerative central nervous system (CNS) disease Pediatr. Rev. 2001 22 175 176 10.1542/pir.22-5-175 11331740

상세보기
5. Cruts M. Theuns J. Van Broeckhoven C. Locus？specific mutation databases for neurodegenerative brain diseases Hum. Mutat. 2012 33 1340 1344 10.1002/humu.22117 22581678

상세보기
6. Singh A. Agarwal S. Singh S. Age related neurodegenerative Alzheimer’s disease: Usage of traditional herbs in therapeutics Neurosci. Lett. 2020 717 134679 10.1016/j.neulet.2019.134679 31816333

상세보기
7. Ascaso F.J. Mateo J. Cabezon L. Casas P. Grzybowski A. Other Neurological Disorders: Migraine, Neurosarcoidosis, Schizophrenia, Obstructive Sleep Apnea？Hypopnea Syndrome and Bipolar Disorder OCT and Imaging in Central Nervous System Diseases Springer New York, NY, USA 2020 317 342
8. Glass C.K. Saijo K. Winner B. Marchetto M.C. Gage F.H. Mechanisms underlying inflammation in neurodegeneration Cell 2010 140 918 934 10.1016/j.cell.2010.02.016 20303880

상세보기
9. Gao Y. Tu D. Yang R. Chu C.H. Hong J.S. Gao H.M. Through Reducing ROS Production, IL？10 Suppresses Caspase？1？Dependent IL？1beta Maturation, thereby Preventing Chronic Neuroinflammation and Neurodegeneration Int. J. Mol. Sci. 2020 21 465 10.3390/ijms21020465

상세보기
10. Abu？Rumeileh S. Vacchiano V. Zenesini C. Polischi B. de Pasqua S. Fileccia E. Mammana A. Di Stasi V. Capellari S. Salvi F. Diagnostic？prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis J. Neurol. 2020 267 1699 1708 10.1007/s00415-020-09761-z 32100123

상세보기
11. Richter J.E. Kahrilas P.J. Johanson J. Maton P. Breiter J.R. Hwang C. Marino V. Hamelin B. Levine J.G. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trial Am. J. Gastroenterol. 2001 96 656 665 10.1111/j.1572-0241.2001.03600.x 11280530

상세보기
12. Olbe L. Carlsson E. Lindberg P. A proton？pump inhibitor expedition: The case histories of omeprazole and esomeprazole Nat. Rev. Drug Discov. 2003 2 132 139 10.1038/nrd1010 12563304

상세보기
13. Yeomans N.D. Tulassay Z. Juhasz L. Grp A.S. Omeprazole was more effective for healing and preventing relapse of ulcers associated with long term NSAID use Gut 1998 43 745
14. Chanchal S.K. Mahajan U.B. Siddharth S. Reddy N. Goyal S.N. Patil P.H. Bommanahalli B.P. Kundu C.N. Patil C.R. Ojha S. In vivo and in vitro protective effects of omeprazole against neuropathic pain Sci. Rep. 2016 6 3007 10.1038/srep30007 27435304

상세보기
15. Hashioka S. Klegeris A. McGeer P.L. Proton Pump Inhibitors Reduce Interferon？gamma？Induced Neurotoxicity and STAT3 Phosphorylation of Human Astrocytes Glia 2011 59 833 840 10.1002/glia.21157 21360757

상세보기
16. Balza E. Piccioli P. Carta S. Lavieri R. Gattorno M. Semino C. Castellani P. Rubartelli A. Proton pump inhibitors protect mice from acute systemic inflammation and induce long？term cross？tolerance Cell Death Dis. 2016 7 10.1038/cddis.2016.218

상세보기
17. Huskey S.E.W. Forseth R.R. Li H.M. Jian Z.G. Catoire A. Zhang J. Ray T. He H. Flarakos J. Mangold J.B. Utilization of Stable Isotope Labeling to Facilitate the Identification of Polar Metabolites of KAF156, an Antimalarial Agent Drug Metab. Dispos. 2016 44 1697 1708 10.1124/dmd.116.072108 27486238

상세보기
18. Ma S.G. Chowdhury S.K. Alton K.B. Application of mass spectrometry for metabolite identification Curr. Drug Metab. 2006 7 503 523 10.2174/138920006777697891 16787159

상세보기
19. Ando S. Tanaka Y. Mass spectrometric studies on brain metabolism, using stable isotopes Mass Spectrom. Rev. 2005 24 865 886 10.1002/mas.20045 16052499

상세보기
20. Dawson G. Measuring brain lipids Bba？Mol. Cell Biol. L 2015 1851 1026 1039 10.1016/j.bbalip.2015.02.007

상세보기
21. Hamilton R.A. Garnett W.R. Kline B.J. Determination of mean valproic acid serum level by assay of a single pooled sample Clin. Pharmacol. Ther. 1981 29 408 413 10.1038/clpt.1981.56 6781809

상세보기
22. Sane R. Agarwal S. Elmquist W.F. Brain Distribution and Bioavailability of Elacridar after Different Routes of Administration in the Mouse Drug Metab. Dispos. 2012 40 1612 1619 10.1124/dmd.112.045930 22611067

상세보기
23. Gampa G. Kim M. Cook-Rostie N. Laramy J.K. Sarkaria J.N. Paradiso L. DePalatis L. Elmquist W.F. Brain Distribution of a Novel MEK Inhibitor E6201: Implications in the Treatment of Melanoma Brain Metastases Drug Metab. Dispos. 2018 46 658 666 10.1124/dmd.117.079194 29437873

상세보기
24. Radwan M.F. Dalby K.N. Kaoud T.S. Propyphenazone-Based Analogues as Prodrugs and Selective Cyclooxygenase-2 Inhibitors Acs Med. Chem. Lett. 2014 5 983 988 10.1021/ml500156v 25221653

상세보기
25. Redasani V.K. Shinde A.B. Surana S.J.J.U. Anti？inflammatory and gastroprotective evaluation of prodrugs of piroxicam Ulcers 2014 10.1155/2014/729754

상세보기
26. Jeremy J.Y. Thompson C.S. Mikhailidis D.P. Dandona P. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo Prostaglandins Leukot Essent Fat. Acids 1990 41 195 199 10.1016/0952-3278(90)90090-8

상세보기
27. Maione F. Minosi P. Di Giannuario A. Raucci F. Chini M.G. De Vita S. Bifulco G. Mascolo N. Pieretti S. Long？Lasting Anti-Inflammatory and Antinociceptive Effects of Acute Ammonium Glycyrrhizinate Administration: Pharmacological, Biochemical, and Docking Studies Molecules 2019 24 2453 10.3390/molecules24132453 31277398

상세보기
28. El？Shenawy S.M. Abdel？Salam O.M. Baiuomy A.R. El？Batran S. Arbid M.S. Studies on the anti-inflammatory and anti？nociceptive effects of melatonin in the rat Pharmacol. Res. 2002 46 235 243 10.1016/S1043-6618(02)00094-4 12220966

상세보기
29. de Lange E.C. Danhof M. de Boer A.G. Breimer D.D. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier Brain Res. Brain Res. Rev. 1997 25 27 49 10.1016/S0165-0173(97)00014-3 9370049

상세보기
30. Cheng F.C. Ho Y.F. Hung L.C. Chen C.F. Tsai T.H. Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high？performance liquid chromatography J. Chromatogr. A 2002 949 35 42 10.1016/S0021-9673(01)01225-0 11999751

상세보기
31. Liu X.R. Chen C.P. Smith B.J. Progress in brain penetration evaluation in drug discovery and development J. Pharmacol. Exp. Ther. 2008 325 349 356 10.1124/jpet.107.130294 18203948

상세보기
32. Ball K. Bouzom F. Scherrmann J.M. Walther B. Decleves X. Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro？in vivo scaling methodology for the blood？brain barrier permeability of two transporter substrates, morphine and oxycodone J. Pharm. Sci. 2012 101 4277 4292 10.1002/jps.23266 22864977

상세보기
33. Shaffer C.L. Defining Neuropharmacokinetic Parameters in CNS Drug Discovery to Determine Cross？Species Pharnnacologic Exposure-Response Relationships Annu. Rep. Med. Chem. 2010 45 55 70
34. Benet L.Z. Effect of route of administration and distribution on drug action J. Pharmacokinet. Biopharm. 1978 6 559 585 10.1007/BF01062110 731418

상세보기
35. Gibaldi M. Feldman S. Route of administration and drug metabolism Eur. J. Pharmacol. 1972 19 323 329 10.1016/0014-2999(72)90098-2 4640856

상세보기
36. Qaisi A.M. Tutunji M.F. Tutunji L.F. Acid decomposition of omeprazole in the absence of thiol: A differential pulse polarographic study at the static mercury drop electrode (SMDE) J. Pharm. Sci. 2006 95 384 391 10.1002/jps.20546 16380990

상세보기
37. Gul W. Sajid S. Hamid F. Bhatti S.J.T.P.I. Effect of acidic Ph. and heat on the degradation of omeprazole and Esomeprazole Pharma. Innov. 2015 4 19
38. Choi M.S. Lee Y.H. Shim C.K. Bioavailabilities of Omeprazole Administered to Rats through Various Routes Arch. Pharm. Res. 1995 18 141 145 10.1007/BF02979185

원문보기 상세보기
39. Kanazawa H. Okada A. Matsushima Y. Yokota H. Okubo S. Mashige F. Nakahara K. Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry J. Chromatogr. A 2002 949 1 9 10.1016/S0021-9673(01)01508-4 11999727

상세보기
40. Tassaneeyakul W. Tassaneeyakul W. Vannaprasaht S. Yamazoe Y. Formation of omeprazole sulphone but not 5？hydroxyomeprazole is inhibited by grapefruit juice Brit. J. Clin. Pharmacol. 2000 49 139 144 10.1046/j.1365-2125.2000.00122.x 10671908

상세보기
41. Weidolf L. Karlsson K.E. Nilsson I. A Metabolic Route of Omeprazole Involving Conjugation with Glutathione Identified in the Rat Drug Metab. Dispos. 1992 20 262 267 1352219

상세보기
42. Andersson T. Pharmacokinetics, metabolism and interactions of acid pump inhibitors: Focus on omeprazole, lansoprazole and pantoprazole Clin. Pharmacokinet. 1996 31 274 10.1007/BF03257497

상세보기
43. Boix C. Ibanez M. Zamora T. Sancho J.V. Niessen W.M.A. Hernandez F. Identification of new omeprazole metabolites in wastewaters and surface waters Sci. Total Environ. 2014 468 706 714 10.1016/j.scitotenv.2013.08.095 24061062

상세보기
44. Martignoni M. Groothuis G.M. de Kanter R.J.E. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction Expert Opin. Drug Metab. Toxicol. 2006 2 875 894 10.1517/17425255.2.6.875 17125407

상세보기
45. Luo Z.H. Jin H.J. Liu H. Yue X.Y. Perlmutter J. Parsons S. Tu Z.D. Exploration of new sulfur？containing analogues and in vivo evaluation of a lead F-18 PET tracer for imaging VAChT in rodent and nonhuman primate J. Nucl. Med. 2016 57 160
46. Kumbar S.S. Hosamani K.M. Shettar A.K. Physicochemical properties, antioxidant and anti？inflammatory activities of coumarin？carbonodithioate hybrids Asian Pac. J. Trop. Biomed. 2018 8 201 206

상세보기
47. Singh D.P. Hashim S.R. Singhal R.G.J.I.J.D.D.R. Anti？inflammatory activity of some new thioether derivatives of quinoxaline Int. J. Drug Dev. Res. 2010 2 810 815
48. Rho H.S. Ahn S.M. Yoo D.S. Kim M.K. Cho D.H. Cho J.Y. Kojyl thioether derivatives having both tyrosinase inhibitory and anti？inflammatory properties Bioorg. Med. Chem. Lett. 2010 20 6569 6571 10.1016/j.bmcl.2010.09.042 20934336

상세보기
49. Patel N.J. Fullone J.S. Anders M.W. Brain uptake of S？(1,2？dichlorovinyl)glutathione and S？(1,2？dichlorovinyl)？L？cysteine, the glutathione and cysteine S？conjugates of the neurotoxin dichloroacetylene Brain Res. Mol. Brain Res. 1993 17 53 58 10.1016/0169-328X(93)90072-W 8381909

상세보기
50. Mizuno K. Takeuchi K. Umehara K. Nakajima M. Identification of Novel Metabolites of Vildagliptin in Rats: Thiazoline？Containing Thiol Adducts Formed via Cysteine or Glutathione Conjugation Drug Metab. Dispos. 2019 47 809 817 10.1124/dmd.119.086546 31097424

상세보기

LOADING...

활용도 분석정보

상세보기

다운로드

내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증